Read more:
Press Release: EUROAPI listing on Euronext Paris expected on May 6, 2022
GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center
MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute…
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone Product
SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
See the original post here:
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
IO Biotech Announces Year-End Results for 2021
ABVC Biopharma Announces Fiscal Year 2021 Financial and Operational Results
Continue reading here:
ABVC Biopharma Announces Fiscal Year 2021 Financial and Operational Results
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
TransCode Therapeutics Reports 2021 Results; Provides Business Update
Continue reading here:
TransCode Therapeutics Reports 2021 Results; Provides Business Update
Vaccinex Announces $6.6 Million Private Placement
Go here to read the rest:
Vaccinex Announces $6.6 Million Private Placement
23andMe to Report FY2022 Third Quarter Financial Results
See more here:
23andMe to Report FY2022 Third Quarter Financial Results
Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus
Applied Molecular Transport Announces Board Appointments
Read the original:
Applied Molecular Transport Announces Board Appointments